Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report

• Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors. • Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma. • Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma. • Only six reported cases, one with compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Paspalj, V., Polterauer, S., Poetsch, N., Reinthaller, A., Grimm, C., Bartl, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Reports and Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253948/
https://www.ncbi.nlm.nih.gov/pubmed/34258357
http://dx.doi.org/10.1016/j.gore.2021.100817
_version_ 1783717625284526080
author Paspalj, V.
Polterauer, S.
Poetsch, N.
Reinthaller, A.
Grimm, C.
Bartl, T.
author_facet Paspalj, V.
Polterauer, S.
Poetsch, N.
Reinthaller, A.
Grimm, C.
Bartl, T.
author_sort Paspalj, V.
collection PubMed
description • Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors. • Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma. • Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma. • Only six reported cases, one with comparable follow-up and outcome.
format Online
Article
Text
id pubmed-8253948
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82539482021-07-12 Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report Paspalj, V. Polterauer, S. Poetsch, N. Reinthaller, A. Grimm, C. Bartl, T. Gynecol Oncol Rep Case Reports and Case Series • Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors. • Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma. • Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma. • Only six reported cases, one with comparable follow-up and outcome. Elsevier 2021-06-24 /pmc/articles/PMC8253948/ /pubmed/34258357 http://dx.doi.org/10.1016/j.gore.2021.100817 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Reports and Case Series
Paspalj, V.
Polterauer, S.
Poetsch, N.
Reinthaller, A.
Grimm, C.
Bartl, T.
Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
title Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
title_full Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
title_fullStr Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
title_full_unstemmed Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
title_short Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
title_sort long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: a case report
topic Case Reports and Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253948/
https://www.ncbi.nlm.nih.gov/pubmed/34258357
http://dx.doi.org/10.1016/j.gore.2021.100817
work_keys_str_mv AT paspaljv longtermsurvivalinmultiresistantmetastaticchoriocarcinomaafterpembrolizumabtreatmentacasereport
AT polterauers longtermsurvivalinmultiresistantmetastaticchoriocarcinomaafterpembrolizumabtreatmentacasereport
AT poetschn longtermsurvivalinmultiresistantmetastaticchoriocarcinomaafterpembrolizumabtreatmentacasereport
AT reinthallera longtermsurvivalinmultiresistantmetastaticchoriocarcinomaafterpembrolizumabtreatmentacasereport
AT grimmc longtermsurvivalinmultiresistantmetastaticchoriocarcinomaafterpembrolizumabtreatmentacasereport
AT bartlt longtermsurvivalinmultiresistantmetastaticchoriocarcinomaafterpembrolizumabtreatmentacasereport

Ejemplares similares